Literature DB >> 17594058

Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy.

Gregor Simonis1, Steffen K Briem, Steffen P Schoen, Manja Bock, Rainer Marquetant, Ruth H Strasser.   

Abstract

OBJECTIVES: Protein kinase C (PKC) is a central enzyme in the regulation of growth and hypertrophy. Little was known on PKC isoform regulation in human heart. Goal of this study was to characterize the isoforms of protein kinase C in human heart, their changes during ontogenesis, and their regulation in myocardial hypertrophy and heart failure.
METHODS: In left ventricular and atrial samples from adults with end-stage dilated cardiomyopathy (DCM), from adults with severe aortic stenosis (AS), from small infants undergoing repair of ventricular septal defects, and from healthy organ donors (CO), activity of protein kinase C and the expression of its isozymes were examined.
RESULTS: In the adult human heart, the isoforms PKC-alpha, PCK-beta, PKC-delta, PKC-epsilon, PKC-lambda/-iota, and PKC-zeta were detected both on protein and on mRNA level. All isozymes are subjected to downregulation during ontogenesis. No evidence, however, exists for an isoform shift from infancy to adulthood. DCM leads to a pronounced upregulation of PKC-beta. Severe left ventricular hypertrophy in AS, however, recruits a distinct isoform pattern, i.e., isoforms PKC-alpha, PKC-delta, PKC-epsilon, PKC-lambda/-iota, and PKC-zeta are upregulated, whereas PKC-beta is not changed under this condition.
CONCLUSION: This work gives evidence for a differential recruitment of human PKC isoforms in various forms of myocardial hypertrophy and heart failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594058     DOI: 10.1007/s11010-007-9533-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  36 in total

Review 1.  Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure.

Authors:  Abdelkarim Sabri; Susan F Steinberg
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

Review 2.  Protein kinase C in cardiac disease and as a potential therapeutic target.

Authors:  Stephen Murphy; William H Frishman
Journal:  Cardiol Rev       Date:  2005 Jan-Feb       Impact factor: 2.644

3.  Protein kinase C isoform expression and activity in the mouse heart.

Authors:  K L Schreiber; L Paquet; B G Allen; H Rindt
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-11       Impact factor: 4.733

Review 4.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

5.  Role of protein kinase C-epsilon in hypertrophy of cultured neonatal rat ventricular myocytes.

Authors:  J B Strait; J L Martin; A Bayer; R Mestril; D M Eble; A M Samarel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-02       Impact factor: 4.733

Review 6.  Protein kinase C isoform diversity in the heart.

Authors:  S F Steinberg; M Goldberg; V O Rybin
Journal:  J Mol Cell Cardiol       Date:  1995-01       Impact factor: 5.000

7.  Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.

Authors:  Gunnar Klein; Arnd Schaefer; Denise Hilfiker-Kleiner; Dagmar Oppermann; Praphulla Shukla; Anja Quint; Eva Podewski; Andres Hilfiker; Frank Schröder; Michael Leitges; Helmut Drexler
Journal:  Circ Res       Date:  2005-03-10       Impact factor: 17.367

8.  PKC-beta is not necessary for cardiac hypertrophy.

Authors:  B B Roman; D L Geenen; M Leitges; P M Buttrick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-05       Impact factor: 4.733

9.  Two distinct mechanisms mediate a differential regulation of protein kinase C isozymes in acute and prolonged myocardial ischemia.

Authors:  R H Strasser; G Simonis; S P Schön; M U Braun; R Ihl-Vahl; C Weinbrenner; R Marquetant; W Kübler
Journal:  Circ Res       Date:  1999-07-09       Impact factor: 17.367

10.  Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity.

Authors:  P Ping; J Zhang; Y Qiu; X L Tang; S Manchikalapudi; X Cao; R Bolli
Journal:  Circ Res       Date:  1997-09       Impact factor: 17.367

View more
  41 in total

Review 1.  βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure.

Authors:  Julio Cesar Batista Ferreira; Patricia Chakur Brum; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2010-10-28       Impact factor: 5.000

2.  Cell-intrinsic functional effects of the α-cardiac myosin Arg-403-Gln mutation in familial hypertrophic cardiomyopathy.

Authors:  Peiying Chuan; Sivaraj Sivaramakrishnan; Euan A Ashley; James A Spudich
Journal:  Biophys J       Date:  2012-06-19       Impact factor: 4.033

3.  Probing muscle ankyrin-repeat protein (MARP) structure and function.

Authors:  Alexander Shiang Lun; Ju Chen; Stephan Lange
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

4.  Interplay between the effects of a Protein Kinase C phosphomimic (T204E) and a dilated cardiomyopathy mutation (K211Δ or R206W) in rat cardiac troponin T blunts the magnitude of muscle length-mediated crossbridge recruitment against the β-myosin heavy chain background.

Authors:  John Jeshurun Michael; Sampath K Gollapudi; Murali Chandra
Journal:  J Muscle Res Cell Motil       Date:  2016-07-13       Impact factor: 2.698

5.  Role of protein kinase C in metabolic regulation of the cardiac Na+ channel.

Authors:  Man Liu; Guangbin Shi; Kai-Chien Yang; Lianzhi Gu; Anumantha G Kanthasamy; Vellareddy Anantharam; Samuel C Dudley
Journal:  Heart Rhythm       Date:  2016-12-15       Impact factor: 6.343

6.  Sirtuin 1 represses PKC-ζ activity through regulating interplay of acetylation and phosphorylation in cardiac hypertrophy.

Authors:  Jingyan Li; Junying Huang; Jing Lu; Zhen Guo; Zhuoming Li; Hui Gao; Panxia Wang; Wenwei Luo; Sidong Cai; Yuehuai Hu; Kaiteng Guo; Luping Wang; Zhenzhen Li; Minghui Wang; Xiaolei Zhang; Peiqing Liu
Journal:  Br J Pharmacol       Date:  2018-12-09       Impact factor: 8.739

7.  Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy.

Authors:  Julio C B Ferreira; Tomoyoshi Koyanagi; Suresh S Palaniyandi; Giovanni Fajardo; Eric N Churchill; Grant Budas; Marie-Helene Disatnik; Daniel Bernstein; Patricia C Brum; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2011-09-02       Impact factor: 5.000

8.  Genetic Reduction in Left Ventricular Protein Kinase C-α and Adverse Ventricular Remodeling in Human Subjects.

Authors:  Ray Hu; Michael P Morley; Jeffrey Brandimarto; Nathan R Tucker; Victoria A Parsons; Sihai D Zhao; Benjamin Meder; Hugo A Katus; Frank Rühle; Monika Stoll; Eric Villard; François Cambien; Honghuang Lin; Nicholas L Smith; Janine F Felix; Ramachandran S Vasan; Pim van der Harst; Christopher Newton-Cheh; Jin Li; Cecilia E Kim; Hakon Hakonarson; Sridhar Hannenhalli; Euan A Ashley; Christine S Moravec; W H Wilson Tang; Marjorie Maillet; Jeffery D Molkentin; Patrick T Ellinor; Kenneth B Margulies; Thomas P Cappola
Journal:  Circ Genom Precis Med       Date:  2018-03

9.  Independent modulation of contractile performance by cardiac troponin I Ser43 and Ser45 in the dynamic sarcomere.

Authors:  Sarah E Lang; Jennifer Schwank; Tamara K Stevenson; Mark A Jensen; Margaret V Westfall
Journal:  J Mol Cell Cardiol       Date:  2014-12-03       Impact factor: 5.000

10.  Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice.

Authors:  Li-qing Weng; Wen-bin Zhang; Yong Ye; Pei-pei Yin; Jie Yuan; Xing-xu Wang; Le Kang; Sha-sha Jiang; Jie-yun You; Jian Wu; Hui Gong; Jun-bo Ge; Yun-zeng Zou
Journal:  Acta Pharmacol Sin       Date:  2014-07-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.